UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment Journal article
Chun‑Yong Sun, Le‑Le Yang, Pan Zhao, Pei‑Zheng Yan, Jia Li, Dong‑Sheng Zhao. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment[J]. HEREDITAS, 2022, 159(1), 44.
Authors:  Chun‑Yong Sun;  Le‑Le Yang;  Pan Zhao;  Pei‑Zheng Yan;  Jia Li; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:2.1/2.6 | Submit date:2023/01/30
Cynarine  Non‑alcoholic Fatty Liver Disease  Network Pharmacology  Integration Analysis  Molecular Docking  
Heparin reversal by an oligoethylene glycol functionalized guanidinocalixarene Journal article
Huang,Qiaoxian, Zhao,Hong, Shui,Mingju, Guo,Dong Sheng, Wang,Ruibing. Heparin reversal by an oligoethylene glycol functionalized guanidinocalixarene[J]. Chemical Science, 2020, 11(35), 9623-9629.
Authors:  Huang,Qiaoxian;  Zhao,Hong;  Shui,Mingju;  Guo,Dong Sheng;  Wang,Ruibing
Favorite | TC[WOS]:38 TC[Scopus]:42  IF:7.6/8.0 | Submit date:2021/03/02